Search Within

Tracy-Ann Moo

Formats
  1. Journal Article (45)
  2. Meeting Abstract (33)
  3. Miscellaneous (9)
  4. Editorial (7)
  5. Book Section (2)
  6. Review (2)
  7. Correspondence (1)
Groups
  1. Josie Robertson Surgery Center (99)
  2. Surgery (99)
  3. Survivorship Research (56)
  4. Epidemiology and Biostatistics (47)
  5. Principal Biostatisticians (33)
  6. GME, Surgery (30)

More Groups

People
  1. Monica Morrow (66)
  2. Audree Tadros (38)
  3. Srinivasa Sevilimedu Veeravalli (33)
  4. Kate Pawloski (25)
  5. Jonas Nelson (23)
  6. Laurie Kirstein (20)

More People

Years
  1. 2025 (5)
  2. 2024 (9)
  3. 2023 (12)
  4. 2022 (17)
  5. 2021 (13)
  6. 2020 (13)

More Years

Publications
  1. Annals of Surgical Oncology (65)
  2. International Journal of Radiation Oncology, Biology, Physics (4)
  3. Journal of Clinical Oncology (4)
  4. British Journal of Surgery (2)
  5. Modern Pathology (2)
  6. Plastic and Reconstructive Surgery (2)

More Publications

Publishers
  1. Springer (68)
  2. Elsevier Inc. (8)
  3. American Society of Clinical Oncology (4)
  4. Lippincott Williams & Wilkins (3)
  5. Oxford University Press (3)
  6. Nature Research (2)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Is clinical exam of the axilla sufficient to select node-positive patients who downstage after NAC for SLNB? A comparison of the accuracy of clinical exam versus MRI
    Journal Article

    Moo, T. A.; Jochelson, M. S.; Zabor, E. C.; Stempel, M.; Raiss, M.; Mamtani, A.; Tadros, A. B.; El-Tamer, M.; Morrow, M.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • ASO author reflections: A negative axillary clinical exam adequately identifies clinically node-positive patients who downstage after NAC and are candidates for SLNB
    Editorial

    Moo, T. A.; Morrow, M.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Triple-positive breast carcinoma: A histopathologic and clinical study of patients treated with neoadjuvant chemotherapy
    Meeting Abstract

    Zeng, J.; Edelweiss, M.; Ross, D.; Moo, T. A.; Brogi, E.; D'Alfonso, T.
    Modern Pathology (2019)

    Fulltext@MSK | Save
  • Accuracy of intraoperative frozen section of sentinel lymph nodes after neoadjuvant chemotherapy for breast carcinoma
    Journal Article

    Grabenstetter, A.; Moo, T. A.; Hajiyeva, S.; Schüffler, P. J.; Khattar, P.; Friedlander, M. A.; McCormack, M. A.; Raiss, M.; Zabor, E. C.; Barrio, A.; more...
    American Journal of Surgical Pathology (2019)

    Fulltext@MSK | Save
  • Triple-positive breast carcinoma: A histopathologic and clinical study of patients treated with neoadjuvant chemotherapy
    Meeting Abstract

    Zeng, J.; Edelweiss, M.; Ross, D.; Moo, T. A.; Brogi, E.; D'Alfonso, T.
    Laboratory Investigation (2019)

    Fulltext@MSK | Save
  • Are we overtreating young women with early-stage breast cancer who elect mastectomy over breast-conservation surgery?
    Meeting Abstract

    Tadros, A.; Moo, T. A.; Stempel, M.; Zabor, E.; Khan, A.; Morrow, M.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • What is the risk of poor outcome of breast conservation therapy in patients with augmented breasts?
    Meeting Abstract

    Tadros, A.; Moo, T.; Zabor, E.; Allen, R. Jr; Morrow, M.; Braunstein, L.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • Is axillary clinical exam alone sufficient to select node-positive patients who downstage after NAC for SLNB? A comparison of the accuracy of MRI versus clinical exam
    Meeting Abstract

    Moo, T.; Jochelson, M.; Zabor, E.; Stempel, M.; Raiss, M.; Tadros, A.; El-Tamer, M.; Morrow, M.
    Annals of Surgical Oncology (2019)

    Fulltext@MSK | Save
  • ASO author reflections: Low-volume sentinel node disease after neoadjuvant chemotherapy is still an indication for axillary dissection
    Journal Article

    Moo, T. A.; Morrow, M.
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • ASO author reflections: Locoregional recurrence rates are low with the selective use of PMRT in patients with T1-2 tumors and one to three positive lymph nodes
    Journal Article

    Moo, T. A.; El-Tamer, M.
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save